ABIGO PHARMA A/S — Credit Rating and Financial Key Figures
CVR number: 12927983
Gydevang 33, 3450 Allerød
info@abigo.dk
tel: 46498676
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 22 575.12 | 12 886.06 | 9 189.04 | ||
| Other operating income | 6 942.02 | 12.30 | |||
| Purchases during the financial year | -10 942.16 | -6 673.27 | -4 362.30 | ||
| External services | -5 677.02 | -2 752.87 | -3 731.00 | ||
| Gross profit | 5 813.21 | 6 205.07 | 12 897.97 | 3 472.22 | 1 095.74 |
| Employee benefit expenses | -5 862.07 | -5 907.49 | -6 851.72 | -3 207.19 | - 982.98 |
| Total depreciation | -6.58 | -15.80 | -15.80 | -5.27 | |
| EBIT | -55.44 | 281.78 | 6 030.45 | 259.77 | 112.76 |
| Other financial income | 9.63 | 0.07 | 2.51 | 151.32 | |
| Other financial expenses | - 119.50 | -86.30 | -90.78 | -46.29 | -3.82 |
| Pre-tax profit | - 174.94 | 205.12 | 5 939.74 | 215.99 | 260.26 |
| Income taxes | 28.90 | -49.76 | -1 309.78 | -50.09 | -58.54 |
| Net earnings | - 146.04 | 155.36 | 4 629.96 | 165.90 | 201.72 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 72.42 | 56.62 | 40.82 | ||
| Tangible assets total | 72.42 | 56.62 | 40.82 | ||
| Investments total | 84.50 | 84.50 | 84.50 | ||
| Long term receivables total | |||||
| Finished products/goods | 2 726.21 | 2 400.10 | 1 541.51 | ||
| Inventories total | 2 726.21 | 2 400.10 | 1 541.51 | ||
| Current trade debtors | 2 979.67 | 3 310.36 | 2 692.67 | 1 805.99 | 671.36 |
| Current amounts owed by group member comp. | 530.36 | 5 089.17 | |||
| Prepayments and accrued income | 206.40 | 87.48 | 190.49 | 41.00 | 162.47 |
| Current other receivables | 59.81 | ||||
| Current deferred tax assets | 378.27 | 328.51 | |||
| Short term receivables total | 3 564.33 | 4 256.71 | 2 883.16 | 1 846.99 | 5 982.82 |
| Cash and bank deposits | 6.34 | 2.01 | 3 407.39 | 4 602.76 | |
| Cash and cash equivalents | 6.34 | 2.01 | 3 407.39 | 4 602.76 | |
| Balance sheet total (assets) | 6 453.80 | 6 799.94 | 7 957.38 | 6 449.75 | 5 982.82 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
| Retained earnings | - 668.11 | - 814.15 | - 658.79 | 3 971.17 | 4 137.07 |
| Profit of the financial year | - 146.04 | 155.36 | 4 629.96 | 165.90 | 201.72 |
| Shareholders equity total | - 314.15 | - 158.79 | 4 471.17 | 4 637.08 | 4 838.79 |
| Provisions | 42.42 | 9.02 | 35.74 | ||
| Capital loans | 1 500.00 | 1 500.00 | |||
| Non-current other liabilities | 190.37 | 551.54 | |||
| Non-current liabilities total | 1 690.37 | 2 051.54 | |||
| Current loans from credit institutions | 1 527.52 | 1 023.63 | |||
| Advances received | 5.60 | ||||
| Current trade creditors | 718.81 | 1 391.74 | 1 195.55 | 573.47 | 390.80 |
| Current owed to group member | 1 267.38 | 216.93 | 399.72 | 224.32 | 668.18 |
| Short-term deferred tax liabilities | 938.85 | 83.49 | 31.81 | ||
| Other non-interest bearing current liabilities | 1 563.87 | 2 274.88 | 909.67 | 922.37 | 11.88 |
| Current liabilities total | 5 077.58 | 4 907.19 | 3 443.79 | 1 803.65 | 1 108.28 |
| Balance sheet total (liabilities) | 6 453.80 | 6 799.94 | 7 957.38 | 6 449.75 | 5 982.82 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.